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Abstract
Juvenile hyaline fibromatosis (JHF) is an unknown hereditary disorder with variable penetrance. 
The characterizations of this disease consist of different signs and symptoms such as multiple 
tumorous (tumor-like) muco-cutaneous proliferation, gingival hypertrophy, perianal lesions, articular 
contractures, and osteolytic lesions. A 3-year-old girl with numerous painless nodular masses on 
her gingival, ear and anal areas is presented in this case report. Based on characteristic histological 
features, the diagnosis of JHF was made. The patient underwent surgery following general anesthesia 
and the above areas were surgically operated with appropriate laser parameters, and the patient was 
able to eat and wash away after a day and was discharged with an antibiotic prescription after one 
day in the hospital and returned to normal after a week. The recurrence occurred in other areas a 
year later, especially in the cheek, the ears and the anal area. Therefore, this rare case is presented 
with recurrence.
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Introduction
Juvenile hyaline fibromatosis (JHF) is an autosomal 
recessive disorder that has variable penetrance. The 
disease has been diagnosed with various tumour-like 
lesions with a muco-cutaneous source and also articular 
contractures, gingival hypertrophy, and osteolytic lesions. 
Patients present with perianal papillomatous lesions 
randomly. It has been suggested that JHF is a naturally 
progressive connective tissue disorder.1-4 The first report 
was made by Murray that called it “peculiar cases of 
molluscum fibrosum”.5 In a study conducted in 1903, 
Whitfield and Robinson described that these cases did 
not belong to neurofibromatosis but should have been 
placed in a multiple fibromata category.5 After that, this 
disease was nearly forgotten until 1962 when Puretic et 
al named the condition “a unique form of mesenchymal 
dysplasia”. JHF is so rare that only less than ninety cases 
have been reported globally.6,7 An autosomal recessive 
inheritance pattern has been reported for JHF. JHF is a 
moral disorder with an unknown etiology that appeared 
because of changes in the capillary morphogenesis 
protein 2 gene. The mutation of the CMG2 gene placed on 
chromosome 4q21. This gene is officially called “anthrax 
toxin receptor 2” (ANTXR2).8 The ANTXR2 gene is, 
therefore, uncharged of producing a specific protein and 
there is a poor understanding of the exact cellular role 
of the protein CMG2. However, being the anthrax toxin 
receptor is the role that CMG2 is best characterized.9,10 
One of the genes that play a part in the three-dimensional 
collagen matrices is CMG2 which was recognized as an 
upregulated gene in endothelial cells.11 In mice, CMG 2 
expressions were evident in endothelial cells in various 
body tissues including intestine, lungs, skin, and vascular 
endothelium and on smooth muscle cells.10 The basement 
membrane arrangement would get disturbed, enabling the 
hyaline substance to spill through and develop in different 
body parts including joints, bones and skin, prompting 
the development of gingival hyperplasia, skin papules, 
osteolytic lesions in bone and articular contractures. The 
tumor is not circumscribed adequately and is portrayed 
by an eosinophilic homogeneous ground substance 
which contains cells similar to a bland fibroblast with 
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bounteous granular cytoplasm.12 The disease is clinically 
characterized by a series of findings including skin papules 
and joint contracture. Gingival hyperplasia is a common 
finding that can be sufficiently severe and interfering 
with feeding and causing poor oral hygiene, infection and 
dental caries.13 Histology can also confirm the diagnosis.14 
The treatment is only based on esthetic and is intended to 
limit the orthopedic disability.14 The early surgical removal 
of skin lesions may help, but recurrences are common.15 
In the oral field, laser systems and their applications have 
made huge progress. This rapid progress can be attributed 
to the fact that lasers allow soft tissue procedures with 
excellent hemostasis and field visibility to be carried out 
efficiently. Lasers offer maximum patient comfort after 
surgery. Thus laser therapy is the treatment of choice in 
this case.16,17
Case Presentation
A 3-year-old girl presented with various painless nodular 
masses on the face around her nose and chin. On 
examination, an anal papule and also gingival hyperplasia 
were noted (Figure 1). 
The consistency of lesions was soft to firm and there 
was no tenderness in palpation. Lymphadenopathy and 
hepatosplenomegaly were not observed. Hematological 
and biochemical investigations were within normal limits. 
No history of consanguinity was present in the parents. 
In the first stage, few specimens were obtained from the 
anal region and cheek and transmitted for a pathological 
diagnosis. Microscopically, a poorly circumscribed 
lesion composed of spindle-shaped cells and benign 
oval in an abundant, homogenous, eosinophilic matrix 
Figure 1. (A) the clinical examination before surgery; (B, C, D, E, F) the 
application of the diode laser for removing oral lesions; (G, H) the final 
result after 7-10 days of healing.
Figure 2. (A) the microscopical view of the lesion shows an amorphous 
hyaline matrix with fibroblast-like cells. (B) the panoramic image shows 
that there is no significant hard tissue disorder due to JHF.
was seen (Figure 2). There were no mitotic figures. The 
ground substance was negative for toluidine blue and 
was positive for PAS. Based on the clinical findings and 
histopathological slides, a diagnosis of JHF was made.
After obtaining consent from the parent, surgery was 
performed under general anesthesia. A diode laser (A.R.C 
- LASER Com, FOX - Germany) with a wavelength of 810 
nm, a power of 4 watts, a pulse width of 20 milliseconds, 
and an interval of 20 milliseconds by a 400-micron optical 
fiber was used by an expert person. Exophytic lesions were 
removed from the gum and anal areas (Figure 3) and the 
patient was discharged from the hospital with antibiotics 
and an anti-Septic prescription after a recovery day. The 
patient was able to eat. After a week, the situation was also 
very good, according to her parents’ acknowledgment. 
However, the patient had a recurrence of lesions within 
one year and this time they appeared more in the cheek 
(Figure 4), the anal area and also the ear (Figure 5). The 
surgery was performed in a sensitive area in the vicinity 
of the cartilage of the ear, and the surgery was done 
according to the previous conditions and the same result 
was yielded and is currently under observation.
Discussion
JHF is considered rare mesenchymal dysplasia that 
is portrayed by numerous tumorous mucocutaneous 
lesions, gingival hypertrophy articular contractures, 
and osteolytic lesions. This disorder has a progressive 
nature, so it requires several surgical interventions and 
physiotherapy.1-4 JHF is a kind of mesenchymal dysplasia 
that was initially named by Drescher et al and Murray 
J. as “peculiar cases of molluscum fibrosum”.5 The 
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alternative equivalent words include puretic syndrome,5 
disseminated painful fibromatosis and fibromatosis 
hyalinica, and multiplex juvenilis. The diagnosis is based 
on histopathology. The histological features of the tumor-
like lesions are characterized by tumor cells and the 
abundant ground substance. The tumor cells have oval 
nuclei and fine granular or vesicular cytoplasm, stained 
pale pink in HE staining. The cells are distributed in 
groups of a few to several in the ground substance. The 
ground substance is eosinophilic and homogeneous 
with some wavy filaments.12 The electron microscopic 
examination of tumor tissue showed that the ground 
substance is composed of delicate filaments.13
Infantile systemic hyalinosis, neurofibromatosis, 
gingival fibromatosis, congenital generalized fibromatosis, 
lipoid proteinosis and Winchester syndrome3 are placed in 
differential diagnosis with JHF, although the histological 
and clinical and immune histochemical findings exclude 
them.
No particular treatment is accessible for JHF. The 
treatment is only based on the preserve aesthetic of 
patients and its aim is to restrain the orthopedic disability. 
Early tumorectomy, intralesional systemic steroids, 
capsulotomy, partial gingivectomy, and physiotherapy are 
required to restrict flexion. Contractures would improve 
the situation of these patients; however, many cases have 
recurrences.18,19
 The diode laser (810-1064 nm) has become very 
popular in general dentistry because of its small size, 
low cost, fiber optic delivery and ease of use for minor 
surgery of oral soft tissue. The advantages of laser 
surgery are relatively hemostasis and outstanding field 
visibility, minimal swelling, scarring and coagulation, 
no need for suturing, reduction in surgical time, and less 
or no postoperative surgical pain and edema. Patients 
undergoing diode laser surgery in the oral cavity seem 
to have less pain. In addition, less risk of edema and the 
dressing layer of denatured protein enhance healing with 
less risk of secondary infection.16,17,20-22
Conclusion
The diagnosis of JHF was made by clinical and 
histopathological solidarity. The precise and early 
Figure 3. The JHF Lesion in the Anal Area Before and During Surgery and 
After Healing for 7-10 Days.
Figure 5. Ear Lesions in the Recurrent Stage and the Removal of Them by 
the Application of the Laser.
Figure 4. (A) The recurrent lesion within 1 year in the cheek. (B, C, D) the 
removal of the recurrent lesion by using a diode laser. (E, F) the condition 
of the oral cavity after healing during 7-10 days.
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diagnosis of this rare disease is very important so that 
no additional therapies are prescribed for them, and it is 
recommended that conservative treatment methods such 
as a surgical laser performed by a skilled person should 
be considered as alternative therapies for these patients.
We recommend further studies in the future possibly 
with other methods in the hope that we can help these 
people to improve the quality of their lives.
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